142217-79-6

• 常用中文名：(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊酮
• 常用英文名：(2R,3S,5S)-5-[2-[[(4-methoxyphenyl)-diphenylmethyl]amino]-6-phenylmethoxypurin-9-yl]-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-one
• CAS号：142217-79-6
• 分子式：C₅₂H₄₇N₅O₅
• 分子量：821.960
• 发布时间：2018-12-06 02:24:31
• 更新时间：2026-07-26 19:18:00

名称

• 中文名: (2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊酮
• 英文名: (2R,3S,5S)-5-[2-[[(4-methoxyphenyl)-diphenylmethyl]amino]-6-phenylmethoxypurin-9-yl]-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-one
• 中文别名: 恩替卡韦杂质2; (2R,3S,5S)-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-(苯基甲氧基)-9H-嘌呤-9-基]-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊酮; (2R,3S,5S)-3-(苄氧基)-5-(6-(苄氧基)-2-((((4-甲氧基苯基)二苯甲基)氨基)-9H-嘌呤-9-基)-2-((苄氧基)甲基)环戊酮(恩替卡韦杂质); 恩替卡韦中间体6; 恩替卡韦杂质
• 英文别名: (2R,3S,5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)-amino)-9H-purin-9; (2R,3S,5S)-5-[2-[[(4-Methoxy-phenyl)diphenylmethyl]amino]-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-[(benzyloxy)methyl]cyclopentanone; Entecavir Impurity 54; EntecavirinterMediate; (2R,3S,5S)-3-(BENZYLOXY)-5-[2-[[(4-METHOXYPHENYL)DIPHENYLMETHYL]AMINO]-6-(BENZYLOXY)-9H-PURIN-9-YL]-2-(BENZYLOXYMETHYL)CYCLOPENTANONE; (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(benzyloxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanone; Entecavir Impurity 14; Entecavir interMediate 6; (2R,3S,5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-Methoxyphenyl)diphenylMethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)Methyl)cyclopentanone; (2R,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentan-1-one; Cyclopentanone, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (2R,3S,5S); (2R,3S,5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)-amino)-9H-purin; (2R,3S,5S)-3-(Benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanone; Entecavir Impurity 2; (2R,3S,5S)-3-(Benzyloxy)-5-[6-(benzyloxy)-2-{[(4-methoxyphenyl)(diphenyl)methyl]amino}-9H-purin-9-yl]-2-[(benzyloxy)methyl]cyclopentanone; (2R,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanone (Entecavir Impurity）; (2R,3S,5S)-5-[2-[[(4-Methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]cyclopentanone; (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-Methoxyphenyl)diphenylMethyl]amino]-6-(benzyloxy)-9H-purin-9-yl]-2-(benzyloxyMethyl)cyclopentanone (interMediate st5); N-oxide impurity2

物化性质

• 密度: 1.2±0.1 g/cm3
• 分子式: C₅₂H₄₇N₅O₅
• 分子量: 821.960
• 精确质量: 821.357727
• PSA: 109.62000
• LogP: 9.67
• 折射率: 1.646

合成路线

142217-78-5 ~% 142217-79-6

文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132

3587-60-8 ~% 142217-79-6

文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132

39939-07-6 ~% 142217-79-6

文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132

110567-22-1 ~% 142217-79-6

文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132

117641-39-1 ~% 142217-79-6

文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132

110567-21-0 ~% 142217-79-6

文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132

142217-77-4 ~% 142217-79-6

文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132

4984-82-1 ~% 142217-79-6

文献：Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132

上下游产品

上游产品  8
142217-78-5 3587-60-8 39939-07-6 110567-22-1
117641-39-1 110567-21-0 142217-77-4 4984-82-1
下游产品  3
142217-81-0 142217-69-4 142217-80-9